Comparison of the Structure of Advanced Organic Electrode Materials, TAPT and "TAQ", by Multinuclear NMR and Stability Analysis.

Authors

J M Litterio, S H Finkelstein, Z Sun, K M Cerri, K Schmidt-Rohr

Published in

The journal of physical chemistry. A. Jul 17, 2026. Epub Jul 17, 2026.

Abstract

The chemical structure of two insoluble tricyclic organic molecules made from the same precursor through different reported synthesis routes and forming promising electrode materials is compared by advanced solid-state ¹³C, ¹⁵N, ¹³C{¹H}, ¹⁵N{¹H}, and ¹⁵N-¹⁵N nuclear magnetic resonance (NMR). One synthesis resulted in TAPT, tetraamino-phenazine-1,4,6,9-tetrone, while several prominent publications identified the product of the other procedure as TAQ, with fewer lithium binding sites due to hydrogen atoms bonded to two nitrogen atoms, which also make the central ring antiaromatic. Peak positions in the ¹³C and ¹⁵N NMR spectra of TAPT and two "TAQ" materials, including ¹⁵N₆-"TAQ", are similar and agree with chemical-shift predictions for TAPT. Differences in line broadening arise from different concentrations of unpaired electrons, confirmed by pronounced differences in spin-lattice relaxation times. Slow ¹⁵N{¹H} and long-range ¹³C{¹H} dipolar dephasing proves that like TAPT, "TAQ" does not contain central N-H groups. The aromatic pyrazine ring in TAPT and "TAQ" is confirmed by the 309 ppm chemical shift of the nonprotonated nitrogen atom. Moderate splittings of the ¹⁵NH₂ and ¹³C-NH₂ NMR signals are shown to be due to symmetry-lowering differences in hydrogen bonding. Mass spectra of TAPT and "TAQ" exhibit matching peaks. Quantum-chemical analyses show that formation of TAQ with its antiaromatic central ring is not thermodynamically favorable and that it would spontaneously tautomerize into a reduced form of TAPT. In conclusion, both TAPT and "TAQ" are tetraamino-phenazine-1,4,6,9-tetrone, and published studies of the properties of "TAQ" are therefore duplicative.

PMID:
42467466
Bibliographic data and abstract were imported from PubMed on 17 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.